205 related articles for article (PubMed ID: 32570259)
1. CASC9 Facilitates Cell Proliferation in Bladder Cancer by Regulating CBX2 Expression.
Huo W; Tan D; Chen Q
Nephron; 2020; 144(8):388-399. PubMed ID: 32570259
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
[TBL] [Abstract][Full Text] [Related]
4. lncRNA CASC9 sponges miR‑758‑3p to promote proliferation and EMT in bladder cancer by upregulating TGF‑β2.
Zhang Z; Chen F; Zhan H; Chen L; Deng Q; Xiong T; Li Y; Ye J
Oncol Rep; 2021 Jan; 45(1):265-277. PubMed ID: 33200222
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CASC9 promotes the progression of retinoblastoma via interacting with miR-145-5p.
Zhang T; Yang J; Gong F; Li L; Li A
Cell Cycle; 2020 Sep; 19(18):2270-2280. PubMed ID: 32772636
[TBL] [Abstract][Full Text] [Related]
6. LncRNA
Chen D; Chen J; Gao J; Zhang Y; Ma Y; Wei W; Wei Y
Cancer Biother Radiopharm; 2020 Jun; 35(5):319-328. PubMed ID: 32412777
[No Abstract] [Full Text] [Related]
7. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA CASC9 promotes pancreatic cancer progression by acting as a ceRNA of miR-497-5p to upregulate expression of CCND1.
Zhou J; Song G; Su M; Zhang H; Yang T; Song Z
Environ Toxicol; 2023 Jun; 38(6):1251-1264. PubMed ID: 36947456
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
Yang Y; Zhang G; Li J; Gong R; Wang Y; Qin Y; Ping Q; Hu L
Pathol Res Pract; 2021 Dec; 228():153676. PubMed ID: 34753061
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression.
Wang F; Zu Y; Zhu S; Yang Y; Huang W; Xie H; Li G
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):231-235. PubMed ID: 30442369
[TBL] [Abstract][Full Text] [Related]
12. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
Zhang M; Xu Y; Yin S; Qiu F
Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
[TBL] [Abstract][Full Text] [Related]
13. LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.
Miao L; Liu HY; Zhou C; He X
J Exp Clin Cancer Res; 2019 Apr; 38(1):143. PubMed ID: 30940184
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA long intergenic non-protein coding RNA 1232 promotes cell proliferation, migration and invasion in bladder cancer via modulating miR-370-5p/PIM3 axis.
Feng F; Yang J; Chen A; Cui M; Li L
J Tissue Eng Regen Med; 2022 Jun; 16(6):575-585. PubMed ID: 35338769
[TBL] [Abstract][Full Text] [Related]
15. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CASC9 attenuates lactate dehydrogenase-mediated oxidative stress and inflammation in spinal cord injury via sponging miR-383-5p.
Guan C; Wang Y
Inflammation; 2021 Jun; 44(3):923-933. PubMed ID: 33438067
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis.
Li C; Zhang J; Zhou Y; Li B
Dig Liver Dis; 2021 Apr; 53(4):509-516. PubMed ID: 33478874
[TBL] [Abstract][Full Text] [Related]
19. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CASC9-1 Facilitates Cell Malignant Behaviors in Cervical Squamous Cell Carcinoma by Targeting miR-383-5p to Up-regulate MAPKAP1.
Gao S; Lv Q; Xu F; Li H; Guo X
Arch Med Res; 2022 Feb; 53(2):138-146. PubMed ID: 34857398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
